Chemotherapy after immune checkpoint inhibitor failure in metastatic melanoma: a retrospective multicentre analysis

SM Goldinger; K Buder-Bakhaya; SN Lo; A Forschner; M McKean; L Zimmer; C Khoo; R Dummer; Z Eroglu; EI Buchbinder; PA Ascierto; R Gutzmer; EA Rozeman; C Hoeller; DB Johnson; A Gesierich; P Koelblinger; N Bennannoune; JV Cohen; KC Kahler; MA Wilson; J Cebon; V Atkinson; JL Smith; O Michielin; GV Long; JC Hassel; B Weide; LE Haydu; D Schadendorf; G McArthur; PA Ott; C Blank; C Robert; R Sullivan; A Hauschild; MS Carlino; C Garbe; MA Davies; AM Menzies

doi:10.1016/j.ejca.2021.11.022

Chemotherapy after immune checkpoint inhibitor failure in metastatic melanoma: a retrospective multicentre analysis

SM Goldinger
, K Buder-Bakhaya
, SN Lo
, A Forschner
, M McKean
, L Zimmer
, C Khoo
, R Dummer
, Z Eroglu
, EI Buchbinder
, PA Ascierto
, R Gutzmer
, EA Rozeman
, C Hoeller
, DB Johnson
, A Gesierich
, P Koelblinger (Co-author)
, N Bennannoune
, JV Cohen
, KC Kahler

MA Wilson, J Cebon, V Atkinson, JL Smith, O Michielin, GV Long, JC Hassel, B Weide, LE Haydu, D Schadendorf, G McArthur, PA Ott, C Blank, C Robert, R Sullivan, A Hauschild, MS Carlino, C Garbe, MA Davies, AM Menzies

Department of Dermatology and Allergology

Research output: Contribution to journal › Original Article › peer-review

47 Citations (Web of Science)

Original language	English
Pages (from-to)	22-33
Journal	EUROPEAN JOURNAL OF CANCER
Volume	162
DOIs	https://doi.org/10.1016/j.ejca.2021.11.022
Publication status	Published - 2022

Keywords

PHASE-III TRIAL
BREAST-CANCER
DOUBLE-BLIND
STAGE-III
PACLITAXEL
DACARBAZINE
IPILIMUMAB
COMBINATION
SORAFENIB
NIVOLUMAB

Access to Document

10.1016/j.ejca.2021.11.022

Cite this

Goldinger, SM., Buder-Bakhaya, K., Lo, SN., Forschner, A., McKean, M., Zimmer, L., Khoo, C., Dummer, R., Eroglu, Z., Buchbinder, EI., Ascierto, PA., Gutzmer, R., Rozeman, EA., Hoeller, C., Johnson, DB., Gesierich, A., Koelblinger, P., Bennannoune, N., Cohen, JV., ... Menzies, AM. (2022). Chemotherapy after immune checkpoint inhibitor failure in metastatic melanoma: a retrospective multicentre analysis. EUROPEAN JOURNAL OF CANCER , 162, 22-33. https://doi.org/10.1016/j.ejca.2021.11.022

Goldinger, SM ; Buder-Bakhaya, K ; Lo, SN et al. / Chemotherapy after immune checkpoint inhibitor failure in metastatic melanoma: a retrospective multicentre analysis. In: EUROPEAN JOURNAL OF CANCER 2022 ; Vol. 162. pp. 22-33.

@article{ff74039c637a40409b86fffad89fea8e,

title = "Chemotherapy after immune checkpoint inhibitor failure in metastatic melanoma: a retrospective multicentre analysis",

keywords = "PHASE-III TRIAL, BREAST-CANCER, DOUBLE-BLIND, STAGE-III, PACLITAXEL, DACARBAZINE, IPILIMUMAB, COMBINATION, SORAFENIB, NIVOLUMAB",

author = "SM Goldinger and K Buder-Bakhaya and SN Lo and A Forschner and M McKean and L Zimmer and C Khoo and R Dummer and Z Eroglu and EI Buchbinder and PA Ascierto and R Gutzmer and EA Rozeman and C Hoeller and DB Johnson and A Gesierich and P Koelblinger and N Bennannoune and JV Cohen and KC Kahler and MA Wilson and J Cebon and V Atkinson and JL Smith and O Michielin and GV Long and JC Hassel and B Weide and LE Haydu and D Schadendorf and G McArthur and PA Ott and C Blank and C Robert and R Sullivan and A Hauschild and MS Carlino and C Garbe and MA Davies and AM Menzies",

note = "K{\"o}lblinger: Department of Dermatology and Allergology, Paracelsus Medical University, Salzburg, Austria",

year = "2022",

doi = "10.1016/j.ejca.2021.11.022",

language = "English",

volume = "162",

pages = "22--33",

journal = "EUROPEAN JOURNAL OF CANCER ",

issn = "0959-8049",

publisher = "Elsevier ",

}

Goldinger, SM, Buder-Bakhaya, K, Lo, SN, Forschner, A, McKean, M, Zimmer, L, Khoo, C, Dummer, R, Eroglu, Z, Buchbinder, EI, Ascierto, PA, Gutzmer, R, Rozeman, EA, Hoeller, C, Johnson, DB, Gesierich, A, Koelblinger, P, Bennannoune, N, Cohen, JV, Kahler, KC, Wilson, MA, Cebon, J, Atkinson, V, Smith, JL, Michielin, O, Long, GV, Hassel, JC, Weide, B, Haydu, LE, Schadendorf, D, McArthur, G, Ott, PA, Blank, C, Robert, C, Sullivan, R, Hauschild, A, Carlino, MS, Garbe, C, Davies, MA & Menzies, AM 2022, 'Chemotherapy after immune checkpoint inhibitor failure in metastatic melanoma: a retrospective multicentre analysis', EUROPEAN JOURNAL OF CANCER , vol. 162, pp. 22-33. https://doi.org/10.1016/j.ejca.2021.11.022

Chemotherapy after immune checkpoint inhibitor failure in metastatic melanoma: a retrospective multicentre analysis. / Goldinger, SM; Buder-Bakhaya, K; Lo, SN et al.
In: EUROPEAN JOURNAL OF CANCER , Vol. 162, 2022, p. 22-33.

Research output: Contribution to journal › Original Article › peer-review

TY - JOUR

T1 - Chemotherapy after immune checkpoint inhibitor failure in metastatic melanoma: a retrospective multicentre analysis

AU - Goldinger, SM

AU - Buder-Bakhaya, K

AU - Lo, SN

AU - Forschner, A

AU - McKean, M

AU - Zimmer, L

AU - Khoo, C

AU - Dummer, R

AU - Eroglu, Z

AU - Buchbinder, EI

AU - Ascierto, PA

AU - Gutzmer, R

AU - Rozeman, EA

AU - Hoeller, C

AU - Johnson, DB

AU - Gesierich, A

AU - Koelblinger, P

AU - Bennannoune, N

AU - Cohen, JV

AU - Kahler, KC

AU - Wilson, MA

AU - Cebon, J

AU - Atkinson, V

AU - Smith, JL

AU - Michielin, O

AU - Long, GV

AU - Hassel, JC

AU - Weide, B

AU - Haydu, LE

AU - Schadendorf, D

AU - McArthur, G

AU - Ott, PA

AU - Blank, C

AU - Robert, C

AU - Sullivan, R

AU - Hauschild, A

AU - Carlino, MS

AU - Garbe, C

AU - Davies, MA

AU - Menzies, AM

N1 - Kölblinger: Department of Dermatology and Allergology, Paracelsus Medical University, Salzburg, Austria

PY - 2022

Y1 - 2022

KW - PHASE-III TRIAL

KW - BREAST-CANCER

KW - DOUBLE-BLIND

KW - STAGE-III

KW - PACLITAXEL

KW - DACARBAZINE

KW - IPILIMUMAB

KW - COMBINATION

KW - SORAFENIB

KW - NIVOLUMAB

U2 - 10.1016/j.ejca.2021.11.022

DO - 10.1016/j.ejca.2021.11.022

M3 - Original Article

C2 - 34952480

SN - 0959-8049

VL - 162

SP - 22

EP - 33

JO - EUROPEAN JOURNAL OF CANCER

JF - EUROPEAN JOURNAL OF CANCER

ER -

Goldinger SM, Buder-Bakhaya K, Lo SN, Forschner A, McKean M, Zimmer L et al. Chemotherapy after immune checkpoint inhibitor failure in metastatic melanoma: a retrospective multicentre analysis. EUROPEAN JOURNAL OF CANCER . 2022;162:22-33. doi: 10.1016/j.ejca.2021.11.022